December 2, 2020
“SOUTH SAN FRANCISCO, Calif., Nov. 30, 2020 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m.… Continue Reading…
November 11, 2020
“Biotech Penny Stocks to Watch: Titan Pharmaceuticals Inc. Titan Pharmaceuticals Inc. (TTNP Stock Report) is a biotech penny stock that shot up by almost 28% by EOD on November 10th. At the beginning of the month, the company announced that… Continue Reading…
June 24, 2020
“Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that it has entered into a co-promotion partnership with Indegene Inc. to establish multichannel digital marketing programs throughout the United States and expand the capabilities for the engagement of health care providers (“HCPs”) who… Continue Reading…
March 11, 2020
“Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately $2.2 million of its common stock… The combined purchase price for one share of common stock and each… Continue Reading…
Recent Comments